Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PMPDP3_171331)
Received: 16 July 2020
Accepted: 22 December 2020
First Online: 5 February 2021
Ethics approval and consent to participate
: This study was approved by the Commission Cantonale d’Ethique de la Recherche sur l’être humain (CER-VD, canton of Vaud, Switzerland), with the Project-ID 2018-00599 (Emergence of neurocognitive alterations and brain function in ASD and ASD risk factors). Parents and/or legal guardians of the TD and 16p11.2 deletion cohorts gave informed consent. The local Ethics committee authorized analysis of retrospective data collected on clinical patients (ASD cohort) in the clinic.
: Not applicable.
: The authors declare that they have no competing interests.